Zobrazeno 1 - 10
of 286
pro vyhledávání: '"MJ Kersten"'
Autor:
S D'Sa, JV Matous, R Advani, C Buske, JJ Castillo, M Gatt, P Kapoor, MJ Kersten, V Leblond, M Leiba, ML Palomba, J Paludo, L Qiu, S Sarosiek, M Shadman, D Talaulikar, CS Tam, A Tedeschi, SK Thomas, I Tohidi-Esfahani, J Trotman, M Varettoni, JMI Vos, R Garcia-Sanz, J San-Miguel, MA Dimopoulos, SP Treon, E Kastritis
Publikováno v:
Seminars in hematology. W.B. Saunders Ltd
The consensus panel 2 (CP2) of the 11th International Workshop on Waldenström's macroglobulinemia (IWWM-11) has reviewed and incorporated current data to update the recommendations for treatment approaches in patients with relapsed or refractory WM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4646fcb4e979b506ad03466c79f2863
https://pure.amc.nl/en/publications/report-of-consensus-panel-2-from-the-11th-international-workshop-on-waldenstroems-macroglobulinemia-on-the-management-of-relapsed-or-refractory-wm-patients(6395fe8f-43ea-44e8-8c1a-86b26327e3da).html
https://pure.amc.nl/en/publications/report-of-consensus-panel-2-from-the-11th-international-workshop-on-waldenstroems-macroglobulinemia-on-the-management-of-relapsed-or-refractory-wm-patients(6395fe8f-43ea-44e8-8c1a-86b26327e3da).html
Autor:
CS Tam, P Kapoor, JJ Castillo, C Buske, SM Ansell, AR Branagan, E Kimby, Y Li, ML Palomba, L Qiu, M Shadman, JP Abeykoon, S Sarosiek, JMI Vos, S Yi, D Stephens, D Roos-Weil, AM Roccaro, P Morel, NC Munshi, KC Anderson, J San-Miguel, R Garcia-Sanz, MA Dimopoulos, SP Treon, MJ Kersten
Publikováno v:
Seminars in hematology. W.B. Saunders Ltd
Recent advances in the understanding of Waldenström macroglobulinemia (WM) biology have impacted the development of effective novel agents and improved our knowledge of how the genomic background of WM may influence selection of therapy. Consensus P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcd28c3ec94eeea574952c74fd4e7892
https://pure.amc.nl/en/publications/report-of-consensus-panel-7-from-the-11th-international-workshop-on-waldenstroem-macroglobulinemia-on-priorities-for-novel-clinical-trials(586d4da0-fcb8-439c-9b02-c5a8501d9eeb).html
https://pure.amc.nl/en/publications/report-of-consensus-panel-7-from-the-11th-international-workshop-on-waldenstroem-macroglobulinemia-on-priorities-for-novel-clinical-trials(586d4da0-fcb8-439c-9b02-c5a8501d9eeb).html
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3549722b70a08cedef3260ff1aedda06
http://europepmc.org/abstract/med/21868814
http://europepmc.org/abstract/med/21868814
Autor:
Maas CCHM; Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands. c.h.m.maas@erasmusmc.nl.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. c.h.m.maas@erasmusmc.nl., van Klaveren D; Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands., Durmaz M; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Amsterdam UMC, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands., Visser O; Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Issa DE; Department of Internal Medicine, Jeroen Bosch Hospital, Den Bosch, The Netherlands., Posthuma EFM; Department of Internal Medicine, Reinier de Graaf Gasthuis, Delft, The Netherlands.; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Zijlstra JM; Amsterdam UMC, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands., Chamuleau MED; Amsterdam UMC, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands., Lugtenburg PJ; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Hematology, Rotterdam, The Netherlands., Kersten MJ; Amsterdam UMC, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands., Dinmohamed AG; Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands. a.dinmohamed@iknl.nl.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. a.dinmohamed@iknl.nl.; Amsterdam UMC, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands. a.dinmohamed@iknl.nl.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands. a.dinmohamed@iknl.nl.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Sep 12; Vol. 14 (1), pp. 157. Date of Electronic Publication: 2024 Sep 12.
Autor:
Hübel K; Department of Internal Medicine Faculty of Medicine and University Hospital Cologne Cologne Germany., Bower M; National Centre for HIV Malignancy, Chelsea and Westminster Hospital London UK., Aurer I; Department of Internal Medicine University Hospital Centre Zagreb Croatia.; Medical School University of Zagreb Zagreb Croatia., Bastos-Oreiro M; Department of Hematology Hospital General Universitario Gregorio Marañon Madrid Spain., Besson C; Department of Clinical Haematology Versailles Hospital Versailles France.; UVSQ, Université Paris-Saclay, UFR Santé Simone Veil, Inserm, CESP Villejuif France., Brunnberg U; Department of Hematology and Oncology Goethe University Frankfurt, University Hospital Frankfurt Germany., Cattaneo C; Department of Medical Oncology, Division of Hematology ASST - Spedali Civili Brescia Italy., Collins S; HIV i-BASE London UK., Cwynarski K; Department of Haematology University College Hospital London UK., Pria AD; National Centre for HIV Malignancy, Chelsea and Westminster Hospital London UK., Hentrich M; Department of Hematology and Oncology Red Cross Hospital Munich, Ludwig Maximilian University Munich Germany., Hoffmann C; ICH Study Center Hamburg Germany., Kersten MJ; Department of Hematology Amsterdam University Medical Centers, Cancer Center Amsterdam Amsterdam The Netherlands., Montoto S; Department of Haemato-Oncology, St Bartholomew's Hospital Barts Health NHS Trust London UK., Navarro JT; Department of Hematology Institut Català d'Oncologia, Josep Carreras Leukaemia Research Institute, Universitat Autònoma de Barcelona Barcelona Spain., Oksenhendler E; Department of Clinical Immunology Hôpital Saint-Louis, APHP Paris France., Re A; Department of Medical Oncology, Division of Hematology ASST - Spedali Civili Brescia Italy., Ribera JM; Department of Hematology Institut Català d'Oncologia, Josep Carreras Leukaemia Research Institute, Universitat Autònoma de Barcelona Barcelona Spain., Schommers P; Department of Internal Medicine Faculty of Medicine and University Hospital Cologne Cologne Germany., von Tresckow B; Department of Hematology and Stem Cell Transplantation West German Cancer Center and German Cancer Consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen Essen Germany., Buske C; Institute of Experimental Cancer Research, Department of Internal Medicine III Ulm Germany., Dreyling M; Department of Medicine III Ludwig-Maximilians-University Munich Germany., Davies A; General Hospital, University Hospital NHS Trust Southampton UK.
Publikováno v:
HemaSphere [Hemasphere] 2024 Sep 03; Vol. 8 (9), pp. e150. Date of Electronic Publication: 2024 Sep 03 (Print Publication: 2024).
Autor:
Spanjaart AM; Department of Hematology, Amsterdam UMC location University of Amsterdam, Cancer Center Amsterdam and LYMMCARE, Amsterdam, The Netherlands., Ljungman P; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge and Karolinska Comprehensive Cancer Center, Stockholm, Sweden., Tridello G; European Society for Blood and Marrow Transplantation (EBMT) Data Office, Department of Medical Statistics & Bioinformatics, Leiden, Netherlands., Schwartz J; European Society for Blood and Marrow Transplantation (EBMT) Leiden Study Unit, European Society for Blood and Marrow Transplantation (EBMT) Data Office, Leiden, Netherlands., Martinez-Cibrián N; Department of Hematology, Hospital Clínic, Barcelona, Spain., Barba P; Department of Hematology, Vall d'Hebron University Hospital, Barcelona, Spain., Kwon M; Department of Hematology, Hospital G. Universitario Gregorio Marañon, Institute of Health Research Gregorio Marañon, Madrid, Spain., Lopez-Corral L; Department of Hematology, Hospital Universitario de Salamanca and IBSAL, Salamanca, Spain., Martinez-Lopez J; Department of Hematology, Hospital Univ. 12 de Octubre, Complutense University, CNIO, Madrid, Spain., Ferra C; Clinical Hematology Department, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Barcelona, Spain., Di Blasi R; Department of Hematology, Assistance Publique Hôpitaux de Paris-Hopital Saint-Louis, Paris, France., Ghesquieres H; Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France., Mutsaers P; Department of Hematology, Erasmus MC Cancer Center, Rotterdam, the Netherlands., Calkoen F; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Jak M; Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands., van Doesum J; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, Netherlands., van der Poel M; Department of Hematology, Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, Netherlands., Maertens J; Deptartment of Hematology, University Hospital Gasthuisberg, Leuven, Belgium., Gambella M; Department of Hematology and Cellular Therapy, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Metafuni E; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica e Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Ciceri F; Hematology and BMT Unit IRCCS San Raffaele Scientific Institute, Milan, Italy., Saccardi R; Cell Therapy and Transfusion Medicine Unit Azienda Ospedaliero Universitaria Careggi, Firenze, Italy., Nicholson E; Department of Haematology, The Royal Marsden Hospital, London, United Kingdom., Tholouli E; Department of Clinical Haematology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK., Matthew C; Adult HSCT unit, Northern Centre for Bone Marrow Transplantation, Newcastle Tyne, UK., Potter V; King's College Hospital NHS Foundation Trust, Department of Haematological Medicine, Denmark Hill, London, UK., Bloor A; Adult Leukaemia and Bone Marrow Transplant Unit, Christie NHS Foundation Trust Hospital, University of Manchester, Manchester, UK., Besley C; Department of Haematology, University Hospitals Bristol and Weston NHSFT, Bristol, UK., Roddie C; Department of Haematology, University College London Hospital, London, UK., Wilson K; Blood and Bone Marrow Transplantation Department, University Hospital of Cardiff, Cardiff, UK., Nagler A; Chaim Sheba Medical Center, Tel Aviv University, Tel Hashomer, Israel., Campos A; Celular Therapy Department, Instituto Portugués de Oncologia do Porto, Francisco Gentil, E.P.E, Porto, Portugal., Petersen SL; Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Folber F; Department of internal Medicine, Hematology and Oncology, Masaryk University Hospital Brno, Brno, Czech Republic., Bader P; Department for Children and Adolescents, Division for Stem Cell Transplantation and Immunology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany., Finke J; Department of Hematology/Oncology/Stem Cell Transplantation, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg im Breisgau, Germany., Kroger N; Department of Stem cell Transplantation, University Hospital Eppendorf, Hamburg, Germany., Knelange N; European Society for Blood and Marrow Transplantation (EBMT) Leiden Study Unit, European Society for Blood and Marrow Transplantation (EBMT) Data Office, Leiden, Netherlands., de La Camara R; Department of Hematology, Hospital Universitario de La Princesa, Madrid, Spain., Kersten MJ; Department of Hematology, Amsterdam UMC location University of Amsterdam, Cancer Center Amsterdam and LYMMCARE, Amsterdam, The Netherlands., Mielke S; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation (CAST), Department of Laboratory Medicine, Karolinska Institutet and University Hospital, Karolinska Comprehensive Cancer Center, Karolinska ATMP Center, Stockholm, Sweden. stephan.mielke@ki.se.; Cellular Therapy and immunobiology working party (CTIWP) of EBMT, . stephan.mielke@ki.se.
Publikováno v:
Leukemia [Leukemia] 2024 Sep; Vol. 38 (9), pp. 1985-1991. Date of Electronic Publication: 2024 Jul 23.
Autor:
Moreno-Arciniegas A; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain., García A; IIS-Fundación Jiménez Díaz, Madrid, Spain., Kelm M; Department of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, University Düsseldorf, Düsseldorf, Germany., D'Amore F; Aarhus University Hospital, Aarhus, Denmark., da Silva MG; Hematology, Instituto Português de Oncologia de Lisboa (IPO Lisboa), Lisbon, Portugal., Sánchez-González J; Philips Healthcare Iberia, Madrid, Spain., Sánchez PL; Hospital Universitario de Salamanca, Salamanca, Spain.; CIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain., López-Fernández T; Cardiology Department, La Paz University Hospital, IdiPAZ Research Institute, Madrid, Spain., Córdoba R; IIS-Fundación Jiménez Díaz, Madrid, Spain., Asteggiano R; Faculty of Medicine, Insubria University, Varese, and Laboratorio Analisi e Ricerca Clinica, Turin, Italy., Camus V; Centre Henri Becquerel, Department of Hematology and INSERM U1245, Rouen, France., Smink J; Department of MR R&D-Clinical Science, Philips, Best, The Netherlands., Ferreira A; Hospital da Luz, Lisbon, Portugal., Kersten MJ; Department of Hematology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Bolaños N; Lymphoma Coalition Europe, Madrid, Spain., Escalera N; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.; CIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain., Pacella E; European Society of Cardiology, Nice, France., Gómez-Talavera S; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.; IIS-Fundación Jiménez Díaz, Madrid, Spain.; CIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain., Quesada A; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain., Rosselló X; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.; CIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.; Hospital Universitari Son Espases-IDISBA, Universitat Illes Balears, Palma de Mallorca, Spain., Ibanez B; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.; IIS-Fundación Jiménez Díaz, Madrid, Spain.; CIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Publikováno v:
European journal of heart failure [Eur J Heart Fail] 2024 Aug 30. Date of Electronic Publication: 2024 Aug 30.
Autor:
Locke FL; Moffitt Cancer Center, Tampa, Florida. Electronic address: frederick.locke@moffitt.org., Neelapu SS; M.D. Anderson Cancer Center, Houston, Texas., Bartlett NL; Washington University School of Medicine, St. Louis, Missouri., Lekakis LJ; University of Miami Health System, Sylvester Comprehensive Cancer Center, Miami, Florida., Jacobson CA; Dana-Farber Cancer Institute, Boston, Massachusetts., Braunschweig I; Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York., Oluwole OO; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee., Siddiqi T; City of Hope National Medical Center, Duarte, California., Lin Y; Mayo Clinic, Rochester, Minnesota., Timmerman JM; UCLA David Geffen School of Medicine, Los Angeles, California., Kersten MJ; Amsterdam UMC, University of Amsterdam, Amsterdam, Cancer Center Amsterdam, Netherlands, on behalf of HOVON/LLPC., Zheng Y; Kite, a Gilead Company, Santa Monica, California., Zhang T; Kite, a Gilead Company, Santa Monica, California., Nater J; Kite, a Gilead Company, Santa Monica, California., Shen R; Kite, a Gilead Company, Santa Monica, California., Miao H; Kite, a Gilead Company, Santa Monica, California., Kim JJ; Kite, a Gilead Company, Santa Monica, California., Miklos DB; Stanford University School of Medicine, Stanford, California.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Aug 24. Date of Electronic Publication: 2024 Aug 24.
Autor:
Brink M; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands., Huisman F; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.; Department of Hematology, Treant Hospital, Emmen, The Netherlands., Meeuwes FO; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.; Department of Hematology, Treant Hospital, Emmen, The Netherlands., van der Poel MWM; Division of Hematology, Department of Interne Medicine, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Kersten MJ; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Wondergem M; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Böhmer L; Department of Hematology, Haga Hospital, The Hague, The Netherlands., Woei-A-Jin FJSH; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium., Visser O; Department of Hematology, Isala Hospital, Zwolle, The Netherlands., Oostvogels R; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands., Jansen PM; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Diepstra A; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands., Snijders TJF; Department of Hematology, Medisch Spectrum Twente, Enschede, The Netherlands., Huls G; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Plattel WJ; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Nijland M; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
Publikováno v:
Blood advances [Blood Adv] 2024 Jul 23; Vol. 8 (14), pp. 3619-3628.
Autor:
Claessen MJAG; Department Research, Sanquin Blood Supply, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam University Medical Centers, Cancer Center Amsterdam, De Boelelaan 1117, 1081HV, Amsterdam, The Netherlands.; Landsteiner Laboratory, Amsterdam University Medical Center, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands., Yagci N; Department Research, Sanquin Blood Supply, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands.; Landsteiner Laboratory, Amsterdam University Medical Center, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands., Fu K; Department Research, Sanquin Blood Supply, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands.; Landsteiner Laboratory, Amsterdam University Medical Center, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands., Brandsma E; Department Research, Sanquin Blood Supply, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands.; Department of Life Sciences, Saxion University of Applied Sciences, M.H. Tromplaan 28, 7513AB, Enschede, The Netherlands., Kersten MJ; Department of Hematology, Amsterdam University Medical Centers, Cancer Center Amsterdam, De Boelelaan 1117, 1081HV, Amsterdam, The Netherlands., von Lindern M; Department Research, Sanquin Blood Supply, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands.; Landsteiner Laboratory, Amsterdam University Medical Center, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands., van den Akker E; Department Research, Sanquin Blood Supply, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands. e.vandenakker@sanquin.nl.; Landsteiner Laboratory, Amsterdam University Medical Center, Plesmanlaan 125, 1066 CX, Amsterdam, The Netherlands. e.vandenakker@sanquin.nl.
Publikováno v:
Scientific reports [Sci Rep] 2024 Jul 06; Vol. 14 (1), pp. 15592. Date of Electronic Publication: 2024 Jul 06.